Background: Association of serum vitamin D (vitD) with leptin (Lep) and tumor necrosis factor-alpha (TNF-α) is not precisely known in overweight hypertensive (OW-HT) postmenopausal (PMP) women. Hence, the present study was carried out to investigate the body mass index (BMI)-based correlation of serum vitD with Lep and TNF-α in OW-HT PMP women.
Methods: Women subjects in their early PMP (n = 346, age: 51 - 60 years) categorized into three groups had main inclusion criteria of specified range of age, BMI and blood pressure (BP). Enzyme-linked immunosorbent assay (ELISA) and other kit methods were employed to investigate the role of various variables in three subject groups (normal weight normotensive (NW-NT, n = 116, BMI (kg/m): 22 - 24.9), normal weight hypertensive (NW-HT, n = 115, BMI: 22 - 24.9) and OW-HT (n = 115, BMI: 25 - 29.9) PMP women).
Results: A significant negative linear correlation of vitD with serum Lep and TNF-α, and a significant positive linear correlation of BMI with Lep and TNF-α in OW-HT PMP women were obtained. Significantly higher levels of serum Lep, TNF-α and interleukin-6 (IL-6) were found in OW-HT PMP women, as compared to NW-HT PMP women.
Conclusions: The present study suggests that decreased serum vitD levels correlate with the Lep and TNF-α in OW-HT PMP women. However, further studies may help understand the impact of vitD in cardiovascular events and the influencing factors in OW-HT PMP women.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753983 | PMC |
| http://dx.doi.org/10.14740/jocmr6148 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serum Vitamin D Level Correlates Significantly With Leptin and Tumor Necrosis Factor-Alpha in Overweight Postmenopausal Women With Hypertension.
J Clin Med Res
January 2025
Department of Physiology, Faculty of Science, University of Karachi, Karachi, Pakistan.
Background: Association of serum vitamin D (vitD) with leptin (Lep) and tumor necrosis factor-alpha (TNF-α) is not precisely known in overweight hypertensive (OW-HT) postmenopausal (PMP) women. Hence, the present study was carried out to investigate the body mass index (BMI)-based correlation of serum vitD with Lep and TNF-α in OW-HT PMP women.
Methods: Women subjects in their early PMP (n = 346, age: 51 - 60 years) categorized into three groups had main inclusion criteria of specified range of age, BMI and blood pressure (BP).
Treating the perimenopause in the UK armed forces: a mixed methods review exploring the confidence of general practitioners.
BJGP Open
January 2025
Academic Department of Military General Practice & Primary Care, Research & Clinical Innovation, ICT Centre, Birmingham, United Kingdom.
Article Synopsis
- Access to high-quality perimenopause care is critical for UK Armed Forces personnel, especially women aged 40-55, but many GPs lack confidence in managing this care, particularly in prescribing hormone replacement therapy (HRT).
- A mixed-methods study assessed the confidence levels of GPs in Defence Primary Health Care (DPHC) regarding perimenopause management, including quantitative surveys and qualitative interviews.
- The results showed a majority of GPs felt confident, but specific gaps in prescribing HRT for younger women were noted; factors like recent training and case exposure influenced confidence, highlighting a need for regional women’s health hubs to improve care and further research to address these confidence issues.
Progress of nations in the organisation of, and structures for, kidney care delivery between 2019 and 2023: cross sectional survey in 148 countries.
BMJ
October 2024
Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Objective: To assess changes in key measures of kidney care using data reported in 2019 and 2023.
Design: Cross sectional survey in 148 countries.
Setting: Surveys from International Society of Nephrology Global Kidney Health Atlas between 2019 and 2023 that included participants from countries in Africa (n=36), Eastern and Central Europe (n=16), Latin America (n=18), the Middle East (n=11), Newly Independent States and Russia (n=10), North America and the Caribbean (n=8), North and East Asia (n=6), Oceania and South East Asia (n=15), South Asia (n=7), and Western Europe (n=21).
Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021.
J Epidemiol Glob Health
December 2024
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Article Synopsis
- Peripheral artery disease (PAD) is a serious health issue globally, causing significant health problems and increasing mortality, prompting the need for more effective management approaches.
- A study analyzing data from the Unified National Electronic Healthcare System (2014-2021) revealed a rising trend in PAD incidences, with 19,507 hospitalizations, predominantly affecting older adults and linked to several comorbidities.
- The findings indicate that conditions like heart failure and acute myocardial infarction enhance mortality risks in PAD patients, reinforcing the need for urgent interventions in Kazakhstan to address this growing health concern.
Pseudomyxoma peritonei arising from mature ovarian teratoma, a rare entity: Report of six cases and review of current literature.
Gynecol Oncol Rep
October 2024
Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand.
Background: Pseudomyxoma peritonei (PMP) is a clinical syndrome characterised by intraperitoneal accumulation of mucus due to mucinous neoplasia. It is a rare condition affecting 1-2 per million individuals per year. The majority of PMP arises from a ruptured mucinous appendiceal tumour, with infrequent occurrences from other primary gastrointestinal tumours and mucinous ovarian tumours.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!